Paul Hahn, None;
Mina Chung, None;
Harry Flynn, Alimera (C), Pfizer (C), Santen (C);
Suber Huang, Bausch&Lomb (C), Lumoptik (I), Notal Vision (C), Second Sight (C), Thrombogenics (S);
Judy Kim, Genentech (F), Regeneron (F), Thrombogenics (S);
Tamer Mahmoud, Alcon (C), Alimera (C);
Srinivas Sadda, Allergan (C), Bausch&Lomb (C), Carl Zeiss Meditec (C), Genentech (C), Optos (C), Regeneron (C);
Pravin Dugel, Abbott (C), Acucela (C), Alcon (C), Alimera (C), Allergan (C), Arctic DX (C), Arctic DX (I), Digisight (C), Digisight (I), Genentech (C), LUX (C), Macusight (C), Macusight (I), Neovisa (I), Neovista (C), Ophthotech (C), Ophthotech (I), ORA (C), Regeneron (C), Thrombogenics (C)